Table 4.
Effects of the intervention in reports of urinary incontinence regarding frequency, severity, and impact on quality of life, assessed using the ICIQ-IU-SF in the study to determine the effects of 3 interventions in facilitating voluntary pelvic floor muscle contractions in women.
| ICIQ-SF | ESG (n = 33) |
PG (n = 33) |
PTG (n = 33) |
CG (n = 33) |
||||
|---|---|---|---|---|---|---|---|---|
| Before | After | Before | After | Before | After | Before | After | |
| Frequency | ||||||||
| Never | 2 (6.1%) | 10 (30.3%) | 2 (6.1%) | 15 (45.4%) | 2 (6.1%) | 9 (27.3%) | 4 (12.1%) | 8 (24.2%) |
| ≤Once a week | 3 (9.1%) | 6 (18.2%) | 6 (18.2%) | 12 (36.4%) | 2 (6.1%) | 6 (18.2%) | 3 (9.1%) | 5 (15.1%) |
| 2–3 times a week | 5 (15.1%) | 2 (6.1%) | 4 (12.1%) | 1 (3.0%) | 4 (12.1%) | 6 (18.2%) | 4 (12.1%) | 7 (21.2%) |
| Once a day | 3 (9.1%) | 5 (15.1%) | 2 (6.1%) | 4 (12.1%) | 4 (12.1%) | 5 (15.1%) | 4 (12.1%) | 4 (12.1%) |
| Several times a day | 15 (45.4%) | 9 (27.3%) | 14 (42.4%) | 0 (0%) | 11 (33.3%) | 5 (15.1%) | 11 (33.3%) | 5 (15.1%) |
| All the time | 5 (15.1%) | 1 (3.0%) | 5 (15.1%) | 1 (3.0%) | 10 (30.3%) | 2 (6.1%) | 7 (21.2%) | 4 (12.1%) |
| Amount | ||||||||
| None | 2 (6.1%) | 10 (30.3%) | 2 (6.1%) | 15 (45.4%) | 2 (6.1%) | 9 (27.3%) | 4 (12.1%) | 8 (24.2%) |
| Small | 16 (48.5%) | 14 (42.4%) | 10 (30.3%) | 15 (45.4%) | 12 (36.4%) | 13 (39.4%) | 7 (21.2%) | 12 (36.4%) |
| Moderate | 6 (18.2%) | 4 (12.1%) | 12 (36.4%) | 2 (6.1%) | 14 (42.4%) | 8 (24.2%) | 9 (27.3%) | 7 (21.2%) |
| Large | 9 (27.3%) | 5 (15.1%) | 9 (27.3%) | 1 (3.0%) | 5 (15.1%) | 3 (9.1%) | 13 (39.4%) | 6 (18.2%) |
| Impact | ||||||||
| None | 2 (6.1%) | 7 (21.2%) | 2 (6.1%) | 13 (39.4%) | 2 (6.1%) | 11 (33.3%) | 3 (9.1%) | 8 (24.2%) |
| Slight | 2 (6.1%) | 7 (21.2%) | 1 (3.0%) | 6 (18.2%) | 2 (6.1%) | 2 (6.1%) | 2 (6.1%) | 4 (12.1%) |
| Moderate | 4 (12.1%) | 5 (15.1%) | 6 (18.2%) | 5 (15.1%) | 6 (18.2%) | 8 (24.2%) | 7 (21.2%) | 3 (9.1%) |
| Severe | 13 (39.4%) | 6 (18.2%) | 10 (30.3%) | 7 (21.2%) | 11 (33.3%) | 5 (15.1%) | 6 (18.2%) | 8 (24.2%) |
| Very severe | 12 (36.4%) | 8 (24.2%) | 14 (42.4%) | 2 (6.1%) | 12 (36.4%) | 7 (21.2%) | 15 (45.4%) | 10 (30.3%) |
| Total ICIQ-SF (0–21) |
14.12 (5.59)b | 9.42 (7.09) | 14.55 (4.94)b | 5.79 (5.58) | 14.24 (5.35)b | 8.85 (6.93) | 14.15 (6.25)b | 10.52 (7.37) |
| aWithin-group differences (95% CI) | 4.70 (1.77–7.65) | 8.76 (5.80–11.71) | 5.39 (2.43–8.35) | 3.64 (0.68–6.59) | ||||
| p-value | p = 0.002 | p < 0.0001 | p = 0.0004 | p = 0.016 | ||||
Analyzed using linear mixed-effects model.
Absolute values with percentages are presented as: n (%).
Means with standard deviation are presented as: mean (SD).
ESG (n = 33), electrical stimulation group; PG (n = 33), palpation group; PTG (n = 33), palpation with posterior pelvic tilt group; CG (n = 33), control group; CI, confidence interval; ICIQ-UI-SF, International Consultation on Incontinence Questionnaire Short Form.
The groups were homogeneous at baseline for the total ICIQ-SF variable.